Arthritis and rheumatism
Journal
Overview
publication venue for
-
Chronic polyarthritis associated with hypogammaglobulinemia. A study of two patients.
1977
-
Systemic lupus erythematosus associated with klinefelter's syndrome.
1977
-
Absent factor II in systemic lupus erythematosus. Immunologic studies and response to corticosteroid therapy.
1976
-
Ethical challenges in rheumatology: a survey of the American College of Rheumatology membership..
65.
2013
-
Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis..
65.
2013
-
Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis..
65.
2013
-
Interferon-α induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis..
65.
2013
-
Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis..
65.
2013
-
Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia..
65.
2013
-
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial..
65.
2013
-
Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial..
65.
2013
-
Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus..
65.
2013
-
In vivo cyclic compression causes cartilage degeneration and subchondral bone changes in mouse tibiae..
65.
2013
-
Willingness and access to joint replacement among African American patients with knee osteoarthritis: a randomized, controlled intervention..
65.
2013
-
Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues..
65.
2013
-
Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts..
65.
2013
-
Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes..
65.
2013
-
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome..
65.
2013
-
Valgus malalignment is a risk factor for lateral knee osteoarthritis incidence and progression: findings from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative..
65.
2013
-
Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus..
64.
2012
-
Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors..
64.
2012
-
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus..
64.
2012
-
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations..
64.
2012
-
Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus..
64.
2012
-
The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment..
64.
2012
-
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial..
64.
2012
-
Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus..
64.
2012
-
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus..
64.
2012
-
Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6..
64.
2012
-
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies..
64.
2012
-
Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14..
64.
2012
-
Association of single-nucleotide polymorphisms in CCR6, TAGAP, and TNFAIP3 with rheumatoid arthritis in African Americans..
64.
2012
-
Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans..
64.
2012
-
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus..
64.
2012
-
Evaluation of TRAF6 in a large multiancestral lupus cohort..
64.
2012
-
Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus..
64.
2012
-
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels..
63.
2011
-
Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis..
63.
2011
-
Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus..
63.
2011
-
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment..
63.
2011
-
Cellular response to prosthetic wear debris differs in patients with and without rheumatoid arthritis..
64.
2011
-
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study..
63.
2011
-
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps..
64.
2011
-
Recommendations for publication of genetic association studies in Arthritis & Rheumatism..
63.
2011
-
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups..
63.
2011
-
Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease..
63.
2011
-
Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: an analysis of individual patient-level data..
63.
2011
-
Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database..
63.
2011
-
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features..
63.
2011
-
Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort..
63.
2011
-
Hypoxia activates the notch signaling pathway in cells of the intervertebral disc: implications in degenerative disc disease..
63.
2011
-
Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus..
63.
2011
-
Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms..
63.
2011
-
Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes..
63.
2011
-
Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis..
62.
2010
-
Associations of cigarette smoking with rheumatoid arthritis in African Americans..
62.
2010
-
Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans..
62.
2010
-
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients..
62.
2010
-
A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis..
62.
2010
-
Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells..
62.
2010
-
Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis..
62.
2010
-
Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system..
62.
2010
-
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy..
62.
2010
-
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients..
62.
2010
-
Trefoil factor 3 is induced during degenerative and inflammatory joint disease, activates matrix metalloproteinases, and enhances apoptosis of articular cartilage chondrocytes..
62.
2010
-
Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort..
62.
2010
-
Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients..
62.
2010
-
Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling..
62.
2010
-
Systemic sclerosis and lupus: points in an interferon-mediated continuum..
62.
2010
-
The New York City Rheumatology Objective Structured Clinical Examination: five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity, and sensitivity to change..
61.
2009
-
Medical decision making in patients with knee pain, meniscal tear, and osteoarthritis..
61.
2009
-
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood..
60.
2009
-
DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes..
60.
2009
-
Skeletal health among African Americans with recent-onset rheumatoid arthritis..
61.
2009
-
Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity..
60.
2009
-
Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy..
60.
2009
-
CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population..
60.
2009
-
A quality indicator set for systemic lupus erythematosus..
61.
2009
-
Rheumatology fellows' perception on training and careers in academia: the American College of Rheumatology Fellow Research and Academic Training Survey..
61.
2009
-
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction..
60.
2009
-
Cited2 modulates hypoxia-inducible factor-dependent expression of vascular endothelial growth factor in nucleus pulposus cells of the rat intervertebral disc..
58.
2008
-
Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis..
58.
2008
-
The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus..
58.
2008
-
Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients..
58.
2008
-
Age- and sex-related patterns of serum interferon-alpha activity in lupus families..
58.
2008
-
Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes..
58.
2008
-
Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis..
59.
2008
-
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease..
58.
2008
-
Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis..
59.
2008
-
Racial differences in expectations of joint replacement surgery outcomes..
59.
2008
-
Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis..
58.
2008
-
Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response..
58.
2008
-
Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus..
58.
2008
-
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture..
58.
2008
-
The development of anticytokine therapeutics for rheumatic diseases..
58.
2008
-
Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept..
56.
2007
-
Multicenter validation of a new quality of life measure in pediatric lupus..
57.
2007
-
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus..
56.
2007
-
Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus..
56.
2007
-
Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis..
56.
2007
-
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals..
56.
2007
-
Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort..
57.
2007
-
Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls..
57.
2007
-
Development of a decision aid to address racial disparities in utilization of knee replacement surgery..
57.
2007
-
Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice..
55.
2006
-
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus..
54.
2006
-
Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population..
54.
2006
-
Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis..
54.
2006
-
Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages..
54.
2006
-
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus..
54.
2006
-
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients..
54.
2006
-
Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus..
54.
2006
-
Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus..
55.
2006
-
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies..
54.
2006
-
Quality of osteoarthritis care for community-dwelling older adults..
55.
2006
-
Longitudinal study of negative workplace events among employed rheumatoid arthritis patients and healthy controls..
53.
2005
-
Racial disparity in knee arthroplasty utilization in the veterans health administration..
53.
2005
-
Racial/ethnic differences in surgical outcomes in veterans following knee or hip arthroplasty..
52.
2005
-
Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia..
53.
2005
-
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)..
52.
2005
-
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia..
52.
2005
-
Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors..
52.
2005
-
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease..
52.
2005
-
Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling..
52.
2005
-
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis..
52.
2005
-
Evidence for two phenotypes in the metabolism of methotrexate to 7-hydroxymethotrexate in patients with rheumatoid arthritis..
52.
2005
-
Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression..
52.
2005
-
Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus..
50.
2004
-
Production of endogenous antibiotics in articular cartilage..
50.
2004
-
The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept..
50.
2004
-
Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways..
50.
2004
-
Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set..
51.
2004
-
A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus..
50.
2004
-
Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale..
51.
2004
-
Religious and nonreligious coping methods among persons with rheumatoid arthritis..
51.
2004
-
WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes..
50.
2004
-
Genomic absence of the gene encoding T cell receptor Vbeta7.2 is linked to the presence of autoantibodies in Sjögren's syndrome..
50.
2004
-
Domains of health-related quality of life important to patients with giant cell arteritis..
49.
2003
-
Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2..
48.
2003
-
Coffee consumption and risk of rheumatoid arthritis..
48.
2003
-
Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial..
48.
2003
-
Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events..
48.
2003
-
Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody..
48.
2003
-
Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies..
48.
2003
-
Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis..
48.
2003
-
Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1..
48.
2003
-
Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families..
48.
2003
-
Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: a placebo-controlled trial..
48.
2003
-
Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles..
48.
2003
-
Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells..
48.
2003
-
Identification of an IL1A gene segment that determines aberrant constitutive expression of interleukin-1 alpha in systemic sclerosis..
48.
2003
-
Differences in expectations of outcome mediate African American/white patient differences in "willingness" to consider joint replacement..
46.
2002
-
Reduced susceptibility to collagen-induced arthritis in DBA/1J mice expressing the TSG-6 transgene..
46.
2002
-
Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus..
46.
2002
-
Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes..
46.
2002
-
Racial differences in social network experience and perceptions of benefit of arthritis treatments among New York City Medicare beneficiaries with self-reported hip and knee pain..
47.
2002
-
Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences..
46.
2002
-
Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy..
47.
2002
-
Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium..
46.
2002
-
Expression of recombination-activating genes and terminal deoxynucleotidyl transferase and secondary rearrangement of immunoglobulin kappa light chains in rheumatoid arthritis synovial tissue..
44.
2001
-
Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue..
44.
2001
-
Rheumatology patient and physician concordance with respect to important health and symptom status outcomes..
45.
2001
-
Variation in perceptions of treatment and self-care practices in elderly with osteoarthritis: a comparison between African American and white patients..
45.
2001
-
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin..
44.
2001
-
Intercellular adhesion molecule 1 expression is required for antiphospholipid antibody-induced pregnancy loss..
44.
2001
-
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)..
44.
2001
-
Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype..
44.
2001
-
Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients..
44.
2001
-
Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein..
43.
2000
-
Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta..
43.
2000
-
Localization of a gene for familial recurrent arthritis..
43.
2000
-
Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome..
43.
2000
-
Validation of the Sapporo criteria for antiphospholipid syndrome..
43.
2000
-
Staphylococcus aureus stimulates inducible nitric oxide synthase in articular cartilage..
42.
1999
-
Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes..
42.
1999
-
Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients..
42.
1999
-
Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage..
42.
1999
-
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome..
42.
1999
-
Association of HLA alleles and clinical features in patients with synovitis of recent onset..
42.
1999
-
Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis..
42.
1999
-
An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera..
42.
1999
-
Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects..
42.
1999
-
Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera..
42.
1999
-
Altered distribution of Fcgamma receptor IIIA alleles in a cohort of Korean patients with lupus nephritis..
42.
1999
-
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody..
42.
1999
-
Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes..
42.
1999
-
Parathyroid hormone-related proteins is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor beta in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate..
41.
1998
-
The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint..
41.
1998
-
Molecular characterization of a CD95 signaling mutant..
41.
1998
-
Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis..
40.
1997
-
Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axl: potential role in autocrine signaling in cartilage..
40.
1997
-
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis..
40.
1997
-
Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases..
40.
1997
-
Fc gammaRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus..
40.
1997
-
Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis..
38.
1995
-
Increased frequency of V beta 17-positive T cells in patients with rheumatoid arthritis..
37.
1994
-
Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial..
37.
1994
-
Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies..
36.
1993
-
An organizational model for developing multidisciplinary clinical research in the academic medical center..
36.
1993
-
Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial..
36.
1993
-
Analysis of immunoglobulin gamma heavy chain expression in synovial tissue of a patient with rheumatoid arthritis..
36.
1993
-
Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome..
35.
1992
-
Antiphospholipid antibody/lupus anticoagulant workshop..
35.
1992
-
A rheumatoid factor from a normal individual encoded by VH2 and V kappa II gene segments..
35.
1992
-
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE..
35.
1992
-
Serologic studies of monozygotic twins with systemic lupus erythematosus..
35.
1992
-
Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience..
34.
1991
-
Relationship of clinical features with psychological status in primary fibromyalgia..
34.
1991
-
Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death..
33.
1990
-
Septic arthritis. Staphylococcal induction of chondrocyte proteolytic activity..
33.
1990
-
High-dose, pulse intravenous methylprednisolone enhances Fc gamma receptor-mediated mononuclear phagocyte function in systemic lupus erythematosus..
32.
1989
-
Pregnancy does not cause systemic lupus erythematosus to worsen..
32.
1989
-
Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus..
31.
1988
-
Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus..
29.
1986
-
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus..
29.
1986
-
Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient..
28.
1985
-
Altered expression of complement receptors as a pathogenetic factor in systemic lupus erythematosus..
27.
1984
-
Psychological factors associated with primary fibromyalgia syndrome..
27.
1984
-
Application of monoclonal antibodies to the characterization of cells eluted from human articular cartilage. Expression of Ia antigens in certain diseases and identification of an 85-kD cell surface molecule accumulated in the pericellular matrix..
26.
1983
-
Total knee arthroplasty in juvenile arthritis..
26.
1983
-
Familial systemic lupus erythematosus in males..
26.
1983
-
Rheumatology education in United States medical school..
24.
1981
-
Manpower and fellowship education in rheumatology, 1980..
24.
1981
-
The unproven remedies committee..
24.
1981
-
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders..
23.
1980
-
Evidence for the presence of receptors for C3 and IgG Fc on human synovial cells..
23.
1980
-
Central nervous system lupus erythematosus. The need for classification..
22.
1979
-
Articular cartilage preservation and storage. I. Application of tissue culture techniques to the storage of viable articular cartilage..
22.
1979
-
Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus..
21.
1978
-
Immunopathologic studies of rheumatoid arthritis. I. Absence of complement-dependent cytotoxicity of rheumatoid sera for rheumatoid synovial cell cultures..
21.
1978
-
Do medical students in the United States learn clinical rheumatology?.
20.
1977
-
Immunologic observations on 9 sets of twins either concordant or discordant for SLE..
19.
1976
-
Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations..
18.
1975
-
Proceedings: Twin studies in systemic lupus erythematosus (SLE)..
18.
1975
-
Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis..
18.
1975
-
In vitro rabbit articular cartilage organ model. I. Morphology and glycosaminoglycan metabolism..
17.
1974
-
In vitro rabbit articular cartilage organ model. II. 35S incorporation in various oxygen tensions..
17.
1974
-
Letter: Spleen size in SLE..
17.
1974
-
Cellular immunity in rheumatic diseases. I. Rheumatoid arthritis..
16.
1973
-
Gonococcal arthritis in two patients with active lupus erythematosus. A diagnostic problem..
14.
1971
-
Diplopia as early sign of temporal arteritis. Report of two cases..
13.
1970
-
Reply: To PMID 23044629..
65.
2013
-
Antiinflammatory strategies, not just B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis: comment on the article by Rovin et al..
64.
2012
-
A time capsule for rheumatology..
58.
2008
-
What journal citations teach us about rheumatic diseases..
58.
2008
-
Does knee malalignment predispose to osteoarthritis? Comment on the articles by Brouwer et al and Hunter et al and the editorial by Sharma..
56.
2007
-
Academic rheumatology: not just a man's world..
52.
2005
-
Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al..
50.
2004
-
Treatment with gonadotropin-releasing hormone agonists and prevention of multiple gestations in lupus or antiphospholipid syndrome patients undergoing in vitro fertilization: comment on the article by Guballa et al..
46.
2002
-
Adoption by lupus patients who are infertile: comment on the article by Guballa et al..
43.
2000
-
Entry criteria influence conclusions about rates of flare in lupus pregnancy: comment on the article by Petri et al..
35.
1992
-
Malnutrition does not ameliorate systemic lupus erythematosus..
23.
1980
-
Absence of ethical discourse in the rheumatology literature: comment on the article by Caplan et al.
2008
-
B cell therapy with the anti-CD22 monoclonal antibody epratuzumab: comment on the editorial by St. Clair and Tedder.
2006
-
Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and Pincus.
2003
-
Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.
2003
-
Scleroderma in women with silicone breast implants: comment on the article by Sánchez-Guerrero et al.
1995
-
Genetics of the Hajdu-Cheney syndrome.
1987
-
Pac-Man phalanx.
1983
-
Mentors and heroes: the foundation and future of rheumatology.
2007
-
Summary of the proceedings of the Institute of Medicine workshop, challenges facing the clinical research enterprise: the response of medical specialty and clinical research societies. How the American College of Rheumatology is addressing areas of concern.
2004
-
Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: report of a consensus meeting.
2004
-
If I am not for myself, who will be for me?
2003
-
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.
1999
-
Do mouse models reflect the diversity of osteoarthritis in humans?.
64.
2012
-
Delay in receiving rheumatology care leads to long-term harm..
62.
2010
-
Transition..
62.
2010
-
The child, grown, becomes independent..
60.
2009
-
The link between structural damage and pain in a genetic model of osteoarthritis and intervertebral disc degeneration: a joint misadventure..
60.
2009
-
Pay for performance in rheumatology: will we get the carrot or the stick?.
59.
2008
-
The HLA-DRB1 shared epitope in Caucasians with rheumatoid arthritis: a lesson learned from tic-tac-toe..
58.
2008
-
Articulating a justice ethic for rheumatology: A critical analysis of disparities in rheumatic diseases..
57.
2007
-
Estrogens and lupus: bubbling cauldron or another overrated Witches' Brew?.
56.
2007
-
Therapy for giant cell arteritis: can we do better?.
54.
2006
-
Are we coming to terms with tumor necrosis factor inhibition in pregnancy?.
54.
2006
-
Journal policies on authorship and disclosures..
55.
2006
-
Journal policies on authorship and disclosures..
54.
2006
-
Are bone morphogenetic proteins effective inducers of cartilage repair? Ex vivo transduction of muscle-derived stem cells..
54.
2006
-
New journal policy regarding registration of clinical trials..
52.
2005
-
Genetic markers of treatment response in rheumatoid arthritis..
50.
2004
-
Interferon-alpha: a new target for therapy in systemic lupus erythematosus?.
48.
2003
-
The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?.
48.
2003
-
Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists..
46.
2002
-
Atherosclerosis and lupus: a work in progress..
44.
2001
-
Issues in cross-cultural research: an overview..
45.
2001
-
Rotator cuff disorders: recognition and management among patients with shoulder pain.
2004
-
Catastrophic antiphospholipid syndrome: where do we stand?
2003
-
Osteoarthritis: a disease of the joint as an organ.
2012
-
Update on hip and knee arthroplasty: current state of evidence.
2005
-
Measuring quality in arthritis care: the Arthritis Foundation's Quality Indicator set for osteoarthritis.
2004
-
Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics.
2004
-
Quality of care indicators for gout management.
2004
-
Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.
2003
-
Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease.
2001
-
The role of the chondrocyte in osteoarthritis.
2000
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)